BioSpace News Archive

Dermaliq Therapeutics, Inc. today announced first patient dosed in a Phase 1b/2a trial with DLQ02, a topical calcineurin inhibitor.

According to the report, the global autoimmune disease diagnostics market was valued at US$ 14.4 Bn in 2021 and is anticipated to expand at a CAGR of 3.8% from 2022 to 2030.

According to the report, the global cord blood banking services market was valued at US$ 25.8 Bn in 2021 and is anticipated to expand at a CAGR of 10.9% from 2022 to 2030.

SPIE, the international society for optics and photonics, and IBM Quantum have selected Wesley Sims, an assistant professor of physics at Morehouse College, as this year’s recipient of the IBM-SPIE HBCU Faculty Accelerator Award in Quantum Optics and Photonics.

Trial Library, Inc., an oncology clinical trials company, announced it has come out of stealth mode and received its first funding to address the need for equity in patient recruitment to oncology clinical trials.

GenScript USA Inc., a subsidiary of GenScript Biotech Corporation, a world-leading biotechnology company, announced the immediate availability of a monkeypox virus PCR test kit.

Quoin Pharmaceuticals Ltd. today provides a business update and announces financial results for the second quarter of 2022 ended June 30, 2022.

Microbot Medical Inc. (Nasdaq: MBOT), announced that it will be presenting the Company’s Self-Cleaning Shunt (SCS) at the 16th Asian Australasian Congress of Neurological Surgeons (AACNS).

GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has approved the clinical trial application for GFH312 in a randomized, double-blinded, placebo-controlled phase II monotherapy study.

LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, today announced operational and financial results for the second quarter ended June 30, 2022.